• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亲水性生物材料静脉水凝胶导管可减少 PICC 和中线导管的并发症。

Hydrophilic biomaterial intravenous hydrogel catheter for complication reduction in PICC and midline catheters.

机构信息

Nursing Research, PICC Excellence,Inc. Griffith University, Brisbane, Queensland, Australia.

出版信息

Expert Rev Med Devices. 2024 Mar;21(3):207-216. doi: 10.1080/17434440.2024.2324885. Epub 2024 Mar 6.

DOI:10.1080/17434440.2024.2324885
PMID:38445649
Abstract

INTRODUCTION

More than 30% of peripherally inserted central catheters (PICCs) and midline catheters experience complications. Most complications are related to thrombotic cellular adherence to catheter materials.

AREAS COVERED

This manuscript outlines PICC and midline catheter complications, the need to reduce complications and how hydrogel catheters may provide a solution to address these unmet needs based on available evidence.

EXPERT OPINION

Patients commonly require PICC or midline catheters for treatment to establish a reliable form of intravenous access. Catheters, while reliable in most cases, are not without complications, including occlusion, thrombosis and infection, each related to cellular adherence to the catheter material. Hydrophilic catheter coatings and composites have been developed to mitigate these thrombotic complications, reduce adherence of blood and bacterial cells to catheters and provide greater patient safety with these devices. Hydrogel materials are highly biocompatible and have been effective in reducing cellular adherence and the formation of biofilms on surfaces. Smooth hydrophilic catheter surfaces are potentially more comfortable for the patient, with reduced friction during insertion and removal. A catheter constructed of hydrophilic biomaterial, a hydrogel composite material, may minimize thrombotic complications in PICC and midline catheters, improving catheter performance and outcomes for patients.

摘要

简介

超过 30%的外周静脉置入中心导管(PICC)和中线导管会出现并发症。大多数并发症与血栓细胞对导管材料的黏附有关。

涵盖领域

本文概述了 PICC 和中线导管的并发症,以及减少并发症的必要性,以及水凝胶导管如何基于现有证据为解决这些未满足的需求提供解决方案。

专家意见

患者通常需要 PICC 或中线导管进行治疗,以建立可靠的静脉通路形式。在大多数情况下,导管是可靠的,但并非没有并发症,包括阻塞、血栓形成和感染,这些都与导管材料上的细胞黏附有关。已经开发出亲水导管涂层和复合材料来减轻这些血栓并发症,减少血液和细菌细胞对导管的黏附,并通过这些设备提高患者安全性。水凝胶材料具有高度的生物相容性,在减少表面细胞黏附和生物膜形成方面非常有效。光滑的亲水导管表面对患者来说可能更舒适,在插入和移除过程中摩擦更小。由亲水生物材料、水凝胶复合材料制成的导管,可能会最大限度地减少 PICC 和中线导管中的血栓并发症,改善导管的性能和患者的预后。

相似文献

1
Hydrophilic biomaterial intravenous hydrogel catheter for complication reduction in PICC and midline catheters.亲水性生物材料静脉水凝胶导管可减少 PICC 和中线导管的并发症。
Expert Rev Med Devices. 2024 Mar;21(3):207-216. doi: 10.1080/17434440.2024.2324885. Epub 2024 Mar 6.
2
Safety and Outcomes of Midline Catheters vs Peripherally Inserted Central Catheters for Patients With Short-term Indications: A Multicenter Study.短期适应证患者中线导管与经外周置入中心静脉导管安全性和结局的多中心研究。
JAMA Intern Med. 2022 Jan 1;182(1):50-58. doi: 10.1001/jamainternmed.2021.6844.
3
Peripherally inserted central venous catheter for pediatric acute leukemia: A retrospective 11-year single-center experience.儿科急性白血病患者应用外周置入中心静脉导管:一项回顾性的 11 年单中心经验。
J Vasc Access. 2024 Sep;25(5):1635-1642. doi: 10.1177/11297298231185222. Epub 2023 Jul 6.
4
Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): a pilot randomised controlled trial.成人急性医院患者外周静脉置入中心静脉导管的中心静脉通路装置固定与敷料有效性研究(CASCADE):一项试点随机对照试验
Trials. 2017 Oct 4;18(1):458. doi: 10.1186/s13063-017-2207-x.
5
Peripherally inserted central catheter-related complications in cancer patients: a prospective study of over 50,000 catheter days.癌症患者外周静脉穿刺中心静脉置管相关并发症:一项超过50000导管日的前瞻性研究
J Vasc Access. 2017 Mar 21;18(2):153-157. doi: 10.5301/jva.5000670. Epub 2017 Feb 8.
6
Peripherally inserted central venous catheters are not superior to central venous catheters in the acute care of surgical patients on the ward.在外周置入中心静脉导管在病房对外科手术患者的急性护理中并不优于中心静脉导管。
World J Surg. 2006 Aug;30(8):1605-19. doi: 10.1007/s00268-005-0174-y.
7
Peripherally inserted central catheter complications in neonates with upper versus lower extremity insertion sites.上肢与下肢穿刺部位的新生儿经外周静脉穿刺中心静脉置管并发症
Adv Neonatal Care. 2013 Jun;13(3):198-204. doi: 10.1097/ANC.0b013e31827e1d01.
8
PICC versus midlines: Comparison of peripherally inserted central catheters and midline catheters with respect to incidence of thromboembolic and infectious complications.经外周静脉穿刺中心静脉置管(PICC)与中置线:血栓栓塞和感染并发症发生率方面的外周插入中心导管(PICC)与中置线的比较。
Am J Surg. 2022 May;223(5):983-987. doi: 10.1016/j.amjsurg.2021.09.029. Epub 2021 Sep 25.
9
Comparison of complication rates and incidences associated with different peripherally inserted central catheters (PICC) in patients with hematological malignancies: a retrospective cohort study.比较不同外周置入中心静脉导管(PICC)在血液病患者中相关并发症发生率和发病率:一项回顾性队列研究。
Leuk Lymphoma. 2020 Jan;61(1):156-164. doi: 10.1080/10428194.2019.1646908. Epub 2019 Aug 7.
10
Patterns of use and outcomes of peripherally inserted central catheters in hospitalized patients with solid tumors: A multicenter study.住院固体肿瘤患者中经外周插入中心静脉导管的使用模式和结局:一项多中心研究。
Cancer. 2022 Oct;128(20):3681-3690. doi: 10.1002/cncr.34410. Epub 2022 Aug 9.

引用本文的文献

1
Lumbar methicillin-resistant infection caused by a peripherally inserted central catheter: A case report.经外周静脉穿刺中心静脉导管引起的耐甲氧西林金黄色葡萄球菌腰椎感染:一例报告。
World J Clin Cases. 2025 Jul 6;13(19):104294. doi: 10.12998/wjcc.v13.i19.104294.
2
The current status and evolution of hemodialysis catheters.血液透析导管的现状与发展
Ren Fail. 2025 Dec;47(1):2524523. doi: 10.1080/0886022X.2025.2524523. Epub 2025 Jul 3.
3
A Comprehensive Review of Progress in Preventing Urinary Infections Associated with the Use of Urinary Catheters: A Dual Analysis of Publications and Patents.
预防导尿管相关尿路感染进展的综合综述:出版物与专利的双重分析
Infect Dis Rep. 2025 Jun 4;17(3):64. doi: 10.3390/idr17030064.
4
Venous access devices (Review).静脉通路装置(综述)
Med Int (Lond). 2025 May 13;5(4):42. doi: 10.3892/mi.2025.241. eCollection 2025 Jul-Aug.
5
Preventive Activity of an Arginine-Based Surfactant on the Formation of Mixed Biofilms of Fluconazole-Resistant and Extended-Spectrum-Beta-Lactamase-Producing on Central Venous Catheters.基于精氨酸的表面活性剂对中心静脉导管上耐氟康唑和产超广谱β-内酰胺酶细菌混合生物膜形成的预防作用
Antibiotics (Basel). 2025 Feb 24;14(3):227. doi: 10.3390/antibiotics14030227.
6
Hydrogels and Microgels: Driving Revolutionary Innovations in Targeted Drug Delivery, Strengthening Infection Management, and Advancing Tissue Repair and Regeneration.水凝胶和微凝胶:推动靶向药物递送、加强感染管理以及促进组织修复与再生方面的革命性创新。
Gels. 2025 Mar 3;11(3):179. doi: 10.3390/gels11030179.
7
Analysis of the preventive effect of upper limb exercise combined with intelligent grip ball on venous thrombosis in patients with peripheral central venous catheters.上肢运动联合智能握力球对中心静脉导管外周置入患者静脉血栓预防效果的分析
Am J Transl Res. 2024 Nov 15;16(11):6709-6717. doi: 10.62347/UVLS3384. eCollection 2024.